Management of the late ocular sequelae of Stevens-Johnson syndrome

Ocular Surface

Volumn 1, Issue 4, 2003, Pages 192-201

  Wall, Vicki ^a   Yen, Michael T ^a   Yang, Mei Chuan ^b   Huang, Andrew J W ^b   Pflugfelder, Stephen C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Amniotic membrane transplantation; Autologous serum; Cyclosporine A; Dermatologic disease; Inflammation; Keratinization; Keratoprosthesis; Limbal stem cell transplantation; Mucous membrane transplantation; Penetrating keratoplasty; Punctal occlusion; Salivary gland autotransplantation; Stevens Johnson syndrome; Subcutaneous abdominal artificial tear reservoir; Therapeutic contact lenses; Vitamin A

Indexed keywords

ALBUMIN; ALLOPURINOL; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIPRURITIC AGENT; BARBITURIC ACID DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN A; IBUPROFEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENYLBUTAZONE; PHENYTOIN; PROTEINASE INHIBITOR; RETINOIC ACID; RETINOL; SULFONAMIDE; TETRACYCLINE;

ACUTE DISEASE; AMNION; AUTOTRANSPLANTATION; BLINKING; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONJUNCTIVITIS; CONTACT LENS; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA LIMBUS; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; DISEASE SEVERITY; DRUG MECHANISM; EYE DISEASE; EYE PROTECTIVE DEVICE; EYELID DISEASE; HUMAN; KERATINIZATION; KERATITIS; KERATOCONJUNCTIVITIS SICCA; KERATOPROSTHESIS; LACRIMAL DUCT; LACRIMAL DUCT OCCLUSION; MEIBOMIAN GLAND; MUCOSA; MUCOUS MEMBRANE PEMPHIGOID; PENETRATING KERATOPLASTY; REVIEW; SALIVARY GLAND; STEM CELL; STEM CELL TRANSPLANTATION; STEVENS JOHNSON SYNDROME; TEAR FILM; TISSUE TRANSPLANTATION; TRICHIASIS; VISUAL IMPAIRMENT;

EID: 24644496219     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70014-9     Document Type: Article

References (76)

1. von Hebra F. On diseases of the skin including the exanthemata, Vol 1. Translated by Fagge CH. London: New Sydenham Society, 1866;285-9
2. Stevens AM, Johnson FL. A new eruptive fever associated with stomatitis and ophthalmia. Report of two cases in children. Am J Dis Child 1922;24:526-33
3. Thomas BA. The so-called Stevens-Johnson syndrome. Br Med J 1950;1:1393-7
4. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 1956;68:355-61
5. Fritsch PO, Elias PM. Erythema multiforme and toxic epidermal necrolysis, in Fitzpatrick TB et al (eds). Dermatology in general medicine. New York, McGraw-Hill, ed 4, 1993
6. Power WJ, Ghoraishi M, Merayo-Lloves J. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 1995;102:1669-76
7. Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003;139:33-6
8. Brett AS, Philips D, Lynn AW. Intravenous immunoglobulin therapy for Stevens-Johnson syndrome. South Med J 2001;94:342-3
9. Foster CS, Fong LP, Azar D, Kenyon KR. Episodic conjunctival inflammation after Stevens-Johnson syndrome. Ophthalmology 1988;95:453-62
10. Chan LS, Soong HK, Foster CS, et al. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome. JAMA 1991;266:1543-6
11. Ezekiel D. Gas permeable haptic lenses. J Br Contact Lens Assoc 1983;6:158-161
12. Romero-Rangel T, Stavrou P, Cotter J, et al. Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol 2000;130:25-32
13. Burns RP, Roberts H, Rich LF. Effect of silicone lenses on corneal epithelial metabolism. Am J Ophthalmol 1971;71:486-9
14. Bacon AS, Astin C, Dart JK. Silicone rubber contact lenses for the compromised cornea. Cornea 1994;13:422-8.
15. Pflugfelder SC. Tear fluid influence on the ocular surface. Adv Exp Med Biol 1998;438:611-7
16. Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin 2000;40:113-22
17. Tsubota K, Goto E, Fujita H, et al.Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999;83:390-95
18. Fox RI, Chan R, Michelson JB, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984;27:459-61
19. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent epithelial defect by autologous serum application. Ophthalmology 1999;106:1984-9
20. Poon AC, Geerling G, Dart JK, et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001;85:1188-97
21. Singer L, Brook U, Romem M, Fried D. Vitamin A in Stevens-Johnson syndrome. Ann Ophthalmol 1989;21:209-10
22. Tseng SC, Maumenee AE, Stark WJ, et al. Topical retinoid treatment for various dry-eye disorders. Ophthalmology 1985;92:717-27. Erratum in: Ophthalmology 1989;96:730
23. Soong HK, Martin NF, Wagoner MD, et al. Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study. Ophthalmology. 1988;95:1442-6
24. Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology 2000;47:119-25
25. Halestrap AP, Connern CP, Griffiths EJ, Kerr PM. Cylosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 1997;174:167-72
26. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000;107:631-9. Erratum in Ophthalmology 2000;107:1220
27. Brignole F, Pisella PJ, Saint Jean M, et al. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. invest Ophthalmol Vis Sci 2001;42:90-5
28. Kunert KS, Tisdale AS, Stern ME, et al. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 2000;118:1489-96
29. Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 2002;120:330-7. Erratum in Arch Ophthalmol 2002;120:1099
30. Yen MT, Pflugfelder SC, Feuer WJ. The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects. Am J Ophthalmol 2001;131:314-23
31. Gilbard JP, Rossi SR, Azar DT, Heyda KG. Effect of punctal occlusion by Freeman silicone plug insertion on tear osmolarity in dry eye disorders. CLAO J 1989;15:216-8
32. Cohen EJ. Punctal occlusion. Arch Ophthalmol 1999;117:389-90
33. Willis RM, Folberg R, Krachmer JH, Holland EJ. The treatment of aqueous-deficient dry eye with removable punctal plugs. A clinical and impression-cytologic study. Ophthalmology 1987;94:514-8
34. Older JJ. Review: the value of radiosurgery in oculoplastics. Ophthal Plast Reconstr Surg 2002;18:214-8
35. Martin RT, Nunery WR, Tanenbaum M. Entropion, trichiasis, and distichiasis, in McCord CD, Tanenbaum M, Nunery WR (eds). Oculoplastic Surgery. New York, Raven Press, 1995, pp 221-47
36. Anderson RL, Harvey JT. Lid splitting and posterior lamella cryosurgery for congenital and acquired distichiasis. Arch Ophthalmol 1981;99:631-4
37. Kezirian GM. Treatment of localized trichiasis with radiosurgery. Ophthal Plast Reconstr Surg 1993;9:260-266.
38. Wolfley D. Excision of individual follicles for the management of congenital distichiasis and localized trichiasis. J Pediatr Ophthalmol Strabismus 1987;24:22-6
39. Huneke JW. Argon laser treatment for trichiasis. Ophthal Plast Reconstr Surg 1992;8:50-5
40. Ti SE, Tow SL, Chee SP. Amniotic membrane transplantation in entropion surgery. Ophthalmology 2001;108:1209-17
41. Shimazaki J, Aiba M, Goto E, et al. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology 2002;109:1285-90
42. Solomon A, Meller D, Prabhasawat P, et al. Amniotic membranes, and deep ulcers. Ophthalmology 2002;109:694-703
43. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997;123:303-12
44. Shimazaki J, Yang HY, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 1997;104:2068-76
45. Pires RT, Tseng SC, Prabhasawat P, et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol 1999;117:1291-7
46. Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 1997;104:974-85
47. Kruse FE, Rohrschneider K, Völcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 1999;106:1504-11
48. Chen HJ, Pires RTF, Tseng SC. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol 2000;84:826-33
49. Solomon A, Rosenblatt M, Monroy D, et al. Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol 2001;85:444-9
50. Lee SB, Li DQ, Tan DT, et al. Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res 2000;20:325-34
51. Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995;14:473-84
52. Honavar SG, Bansal AK, Sangwan VS, Rao GN. Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology 2000;975-9
53. Shore JW, Foster CS, Westfall CT, Rubin PA. Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 1992;99:383-95
54. Daya SM, Ilari FA. Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology 2001;108:126-33
55. Croasdale CR, Schwartz GS, Malling JV, Holland EJ. Keratolimbal allograft: recommendations for tissue procurement and preparation by eye banks, and standard surgical technique. Cornea 1999;18:52-8
56. Tsubota K, Satake Y, Kaido M, et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med 1999;340:1697-703
57. Solomon A, Ellies P, Anderson DF, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 2002;109:1159-66
58. Ilari L, Daya SM. Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology 2002;109:1278-84
59. Whitsett CF, Stulting RD. The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci 1984;25:519-24
60. Williams KA, Coster DJ. The role of the limbus in corneal allograft rejection. Eye 1989;3:158-66
61. Tsubota K, Toda I, Saito H, et al. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology 1995;102:1486-95
62. Pellegrini G, Traverso CE, Franzi AT, et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 1997;349:990-3
63. Koizumi N, Inatomi T, Suzuki T, et al. Cultivated corneal epithelial transplantation for ocular surface reconstruction in acute phase of Stevens-Johnson syndrome. Arch Ophthalmol 2001;119:298-300
64. Torfi H, Schwab IR, Isseroff RR. Transplantation of cultured autologous limbal stem cells for ocular surface disease. In Vitro 1996;32:47A.
65. Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 2000;343:86-93
66. Grueterich M, Espana EM, Touhami A, et al. Phenotypic study of a case with successful transplantation of ex vivo expanded human limbal epithelium for unilateral total limbal stem cell deficiency. Ophthalmology 2002;109:1547-52
67. Hicks CR, Crawford GJ, Lou X, et al. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications. Eye 2003;17:385-92
68. Dohlman CH, Power WJ. Keratoprosthesis, in Albert D, Jakobiec F (eds). Principles and practice of ophthalmology. Philadelphia, WB Saunders, 2000, pp 1069-79
69. Lund OE. Keratoprosthesis: 25 years of experience. Refract Corneal Surg 1993;9:186
70. Dohlman CH, Schneider HA, Doane MG. Prosthokeratoplasty. AmJ Ophthalmol 1974;77:694-70.
71. Dohlman CH, Doane MG. Some factors influencing outcome after keratoprosthesis surgery. Cornea 1994;13:214-8
72. Strampelli B. Osteo-odonto-keratoprosthesis. Ann Ottalmol Clin Ocul 1963;89:1039-42
73. Sieg P, Geerling G, Kosmehl H, et al. Microvascular submandibular gland transfer for severe cases of keratoconjunctivitis sicca. Plast Reconstr Surg 2000;106:554-60
74. Yu G, Zhu Z, Mao C, Cai Z, Zou L, Lu L. [Microvascular submandibular gland transfer for severe keratoconjunctivitis sicca: operation key points, prevention and management of complications.] Zhonghua Kou Qiang Yi Xue Za Zhi. 2002;37(5):353-5.
75. Jia G, Wang Y, Lu L, Wang X, Li Z. [Reconstructive lacrimal gland with free submandibular gland transfer for management of xerophthalmia] Zhonghua Yan Ke Za Zhi. 1998 Sep;34(5):388-90.
76. Murube J, Murube E, Chen Zhuo L, Rivas L. Subcutaneous abdominal artificial tears pump-reservoir for severe dry eye. Orbit 2003;22:29-40